Biotecnología

Biotecnología

NEOsphere, Kymera Therapeutics Collaborate on Novel Molecular Glue Target Discovery
16/05/2024 - Aim to create opportunities to target previously undruggable disease-causing proteins.
Ingenza Secures Innovation Funding to Expand codABLE Gene Design Algorithm
06/05/2024 - Will adapt its machine learning platform to precisely control recombinant protein expression in Pichia pastoris.
Abzena Introduces Enhanced Bioassay Platform
02/05/2024 - EpiScreen 2.0 predicts and evaluates potential risks of preclinical immunogenicity in protein, antibody and gene therapy therapeutics.
Fujifilm & Predictive Oncology Tackle Protein Interference
02/05/2024 - Enter a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.
Lonza Expands Spray-Drying Services for Protein-Based Inhaled Therapies
03/04/2024 - New offering provides clinical and commercial manufacturing services at a kilogram scale from Lonza’s Bend (US) site.
Samsung Life Science Fund Invests in BrickBio
24/03/2024 - Samsung affiliates will work with BrickBio to evaluate, manufacture, and develop therapies using BrickBio's protein engineering technology.
BostonGene Named Akoya Biosciences' Qualified CRO
24/03/2024 - Will offer end-to-end spatial biology solutions to life sciences researchers for advanced spatial proteomics analysis.
ProteoNic Biosciences Partners with Ginkgo Bioworks to Support Clients
15/03/2024 - Grants Ginkgo Bioworks’ customers access to ProteoNic's vector technology.
Key Proteo to Build New CLIA-Certified Lab
11/03/2024 - Aims to expand its scope of operations to serve unaddressed newborn screening needs.
Polyplus Receives GMP Certification for Recombinant Protein & DNA Production
07/03/2024 - Also adds an additional GMP clean room for the production of GMP cell banks.
New Ways to Predict How Well Vaccines Protect Against Tuberculosis, Tularemia and Other Bacteria That Live Inside Cells
07/03/2024 - A description of Karen Elkins's research program and related publications.
VantAI, BMS Partner to Accelerate Molecular Glue Drug Discovery
22/02/2024 - Will leverage VantAI's geometric deep learning capabilities with Bristol Myers Squibb’s expertise in targeted protein degradation.
Firefly Bio Debuts with $94M Series A Funding Round
22/02/2024 - Funding will support its novel platform for treating cancer by merging antibody-drug conjugates with protein degraders.
Biognosys Opens New Proteomics Facility in MA
01/02/2024 - Expansion facilitates access to select proteomics contract research organization (CRO) services for the company’s US biopharma customers.
Entos Pharma Launches GMP Clinical Mfg. Facility in Carlsbad
30/01/2024 - Will manufacture genetic medicines based on Entos Fusogenix PLV platform, including recombinant protein, mRNA, and plasmid DNA.
AGC Biologics to Open New Manufacturing Site in Japan
19/01/2024 - Will offer preclinical through commercial services for mammalian-based protein biologics, cell therapies, and messenger RNA.
Abzena Launches AbZelect Platforms for Cell Line Development
19/01/2024 - Designed to enable the rapid generation and selection of high-yielding mammalian CHO cell lines for therapeutic protein and recombinant vaccine production.
Eurofins Alphora Completes Pilot Scale mAbs Development Facility
19/01/2024 - 3,300 sq.-ft. facility dedicated to development and scaling of mAbs and other mammalian-based therapeutic proteins.
Healis, CKD Bio Ink Supply Deal to Develop Neuromodulator Protein
03/01/2024 - Aims to develop CKDB-501 for major depressive disorder and post-traumatic stress disorder.
CARVYKTI
26/12/2023 - For the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an...